Amir Nashat

Insider Reports History

Location
10835 Road To The Cure, Suite 205, San Diego, CA
Signature
By: /s/ Lauren Crockett, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amir Nashat:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp Director Common Stock 38.6K $608K $15.74 May 9, 2024 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 198K $302K $1.53 Sep 11, 2025 Indirect
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 Aug 16, 2024 By Polaris Entrepreneurs' Fund VII, L.P.
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 Aug 16, 2024 By Polaris Partners VII, L.P.
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 Aug 16, 2024 Direct
Scholar Rock Holding Corp Director Common Stock 0 $0 $15.74 May 9, 2024 Indirect
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 36K Jun 21, 2023 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 17.5K Jun 1, 2022 Direct
Metacrine, Inc. Director, 10%+ Owner Stock Option (right to buy) 16.5K May 18, 2022 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Stock Option (Right to Buy) 9K Jun 25, 2025 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Series A Prime Preferred Stock 0 Oct 15, 2024 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Series B Preferred Stock 0 Oct 15, 2024 Indirect
Morphic Holding, Inc. Director Stock Option (Right to Buy) 0 Aug 16, 2024 Direct

Insider Reports Filed by Amir Nashat

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Sep 11, 2025 2 $2M 4 Sep 11, 2025 Director, 10%+ Owner
CAMP Camp4 Therapeutics Corp Jun 25, 2025 1 $0 4 Jun 27, 2025 Director, 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 15, 2024 9 $10M 4 Oct 15, 2024 Director, 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 Director, 10%+ Owner
MORF Morphic Holding, Inc. Aug 16, 2024 9 $0 4 Aug 20, 2024 Director
MORF Morphic Holding, Inc. Jun 4, 2024 1 $0 4 Jun 5, 2024 Director
SRRK Scholar Rock Holding Corp May 9, 2024 9 $0 4 May 13, 2024 Director
SRRK Scholar Rock Holding Corp Dec 27, 2023 1 $0 4 Dec 29, 2023 Director
SRRK Scholar Rock Holding Corp Dec 13, 2023 9 $0 4 Dec 15, 2023 Director
SRRK Scholar Rock Holding Corp Nov 20, 2023 9 $0 4 Nov 22, 2023 Director
MORF Morphic Holding, Inc. Jun 28, 2023 5 $0 4 Jun 30, 2023 Director
SRRK Scholar Rock Holding Corp Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
MORF Morphic Holding, Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
SRRK Scholar Rock Holding Corp Jun 22, 2022 4 $7.34M 4 Jun 24, 2022 Director
MORF Morphic Holding, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
SRRK Scholar Rock Holding Corp May 26, 2022 1 $0 4 May 27, 2022 Director
MTCR Metacrine, Inc. May 18, 2022 1 $0 4 Sep 6, 2022 Director, 10%+ Owner
SRRK Scholar Rock Holding Corp Nov 17, 2021 9 $0 4 Nov 19, 2021 Director
MORF Morphic Holding, Inc. Jun 16, 2021 1 $0 4/A Apr 29, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
SRRK Scholar Rock Holding Corp May 27, 2021 1 $0 4 Jun 1, 2021 Director
MTCR Metacrine, Inc. May 24, 2021 1 $0 4 May 25, 2021 Director, 10%+ Owner
MORF Morphic Holding, Inc. May 21, 2021 2 -$10.6M 4 May 25, 2021 Director